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Several types of nanocrystalline apatites have been described, obtained in various ways. Among
these, biomimetic nanocrystalline apatites (BNA), whose characteristics are close to those of biological
apatites, have been shown to exhibit specific properties mainly related to their surface structure and
composition. The aim of this paper is to review current knowledge of these compounds.
2. Biomimetic nanocrystalline apatites
The term biomimetic is used with different meanings; applied to materials it is often intended to
denote preparative techniques and/or properties mimicking those of biological materials. BNA are
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defined as apatites exhibiting the main characteristics of biologically produced apatites found, for
example, in calcified tissues of vertebrates or ectopic calcifications. Four main characteristics can be
identified:
! Non-stoichiometric composition.
! Presence of CO3
2" and HPO4
2" ions.
! Nanometric platelet crystals.
! Hydrated layer on the crystal surface.
2.1. Non-stoichiometry
Several types of non-stoichiometric apatites can be distinguished depending on the substituents
and vacancies present in these widespread structures. Stoichiometric apatites are ideally represented
by the following formulae:
Me10ðXO4Þ6Y2 (1.1)
whereMe represents a bivalent ion (Ca, Sr, Ba, Pb, Cd, Mn,…), XO4 a trivalent anion (PO4, AsO4, VO4,…)
and Y a monovalent anion (F, Cl, Br, OH,…). A model compound of biomimetic apatite is the calcium
phosphate hydroxyapatite:
Ca10ðPO4Þ6ðOHÞ2 (1.2)
Solid solutions often exist between apatites with different compositions [24]. Non-stoichiometry is
related to vacancies in Me sites and Y sites. Significant number of vacancies in XO4 sites have never
been reported and theoretical calculations have shown that the creation of PO4 vacancies in calcium
phosphate hydroxyapatite would be associated with strong destabilization of the structure [17]. In
other terms, the creation of large defects like XO4 vacancies in the apatite structure would produce a
collapse of the structure and the formation of other phases, whereas small defects like those corre-
sponding to Me and Y vacancies allow preservation of the structure, although they are associated with
a loss of cohesion and stability. Full characterization of non-stoichiometry in apatites thus requires, in
principle, determination of the two atomic ratios, Me/X and Y/X, assuming that the number of va-
cancies in X sites is negligible. In a number of cases, however, only the Me/X ratio is considered, for




2" in biomimetic apatites
Non-stoichiometry in BNA is mainly related to the substitution of PO4
3" ions by bivalent ions like
CO3
2" (leading to type B carbonated apatites) or HPO4
2". All biological apatites contain variable amounts
of carbonate and hydrogen phosphate ions [23,4]. In bone the level of HPO4
2" ions has been found to
decrease with age and to be associated with an increase in the CO3
2" content. These incorporations of
bivalent ions, which are related to a loss of negative charge, are mainly compensated for by a complex
defect associating calcium and OH" vacancies, as represented in the following formulae:
Ca10"xðPO4Þ6"xðHPO4;CO3ÞxðOHÞ2"x (1.3)
Rietveld analyses of non-stoichiometric apatites have partially confirmed this compensation
mechanism [29,30], initially based on composition considerations only [9]. Other compensation
mechanisms involving Ca2þ substitution by Naþ have also been shown, in the case of carbonated
apatites, although such substitutions remain very limited in bone mineral. The existence of vacancies
clustering in biomimetic apatites, once proposed on the basis of Pauling's rule relative to crystal
constitutions, is still debated. More accurate chemical formulas taking into account slight deviations
from Formula (1.3) have been proposed [24] that result in a disconnection of the content of vacancies
from the proportion of bivalent ions in PO4
3" sites. It should be noted that the quantity of OH", like that
of HPO4
2" ions, remains difficult to determine with accuracy, which introduces some imprecision in the
chemical composition of biomimetic apatites.
2.3. Crystal morphologies
Crystal morphology is an important point as it has consequences for surface reactivity and in-
teractions with biological molecules. Although controversies have been raised on the crystal
morphology of bone apatites, it is accepted that the nanocrystals exhibit irregular plate-like shapes
elongated along the c axis of the hexagonal apatite structure [15]. Generally, most geological or syn-
thetic well-crystallized apatites show needle-like crystals, also elongated along the c axis; however,
among biological apatites, only mature tooth enamel crystals, which are not really nanocrystals, adopt
this morphology. The peculiar morphology of biological nanocrystals has been related to the existence
of crystalline precursor phases, like dicalcium phosphate dihydrate (brushite) and octacalcium phos-
phate or amorphous calcium phosphate. This point, however, remains debated and no clear answer has
been given that strictly excludes preparation or observation artifacts. The plate-like morphology is also
observed for synthetic biomimetic nanocrystals, so cannot be related to biological conditions of crystal
growth only.
2.4. The hydrated surface layer
Biological nanocrystals are characterized by the existence of non-apatitic domains, which have
sometimes been interpreted as a sign of formation of precursor phases. In fact several consistent
data, essentially obtained using spectroscopic methods, suggest that nanocrystals in bone are
covered by a hydrated layer with a composition and structure different from that of crystalline
apatite as schematized in Fig. 1. Fourier transform infrared spectroscopic (FTIR) investigations of
bone crystals have revealed the existence of non-apatitic environments of CO3
2" and HPO4
2" with
specific spectral features [4,5]. Solid state nuclear magnetic resonance (SS-NMR) studies of bio-
mimetic apatites with similar FTIR characteristics as bone mineral have additionally established that
the non-apatitic species were close to water molecules in domains distinct from apatite [26,28].
Finally, spectroscopic (FTIR and SS-NMR) analyses of wet samples revealed that the surface hydrated
layers were structured, and that the structuralization was related to surface composition and easily
altered by fast, reversible ionic exchange, leaving the apatite domains unchanged [7,8]. However, the
hydrated layer appears rather fragile and cannot be preserved in dried samples, leading to
amorphous-like domains that can be observed by high resolution transmission electron spectros-
copy (HR-TEM) [3].
The hydrated layer shall not be considered as a Stern double layer but a result of the precipitation
process of biomimetic apatites. This layer is believed to decrease the water-crystal interfacial energy
and to favour the formation of the nanocrystals in aqueous media.
From a thermodynamic point of view, however, the apatite domains are the most stable and with
time they develop at the expense of the hydrated layer, incorporating some of the mineral ions present
in this layer. Although the global composition of the nanocrystals can be determined by classical
methods, the distribution of species between the hydrated layer and the apatite core seems more
difficult to establish. Different data obtained by SS-NMR and FTIR suggest a predominance of bivalent
ions in the hydrated layer [7,8]. Thus, the global composition of the nanocrystals does not represent
that of the apatite domains and in the absence of adequate analytical techniques it seems, at this date,
difficult to precisely assess the composition of the different domains of biomimetic nanocrystals. A
consequence is that their global composition should not be discussed as related exclusively to apatite
chemistry.
The structure of the hydrated layer is still unknown. FTIR data suggest an analogy with the hydrated
layer of octacalcium phosphate, also containing bivalent species; however, some specific features of
OCP aremissing in spectra of the hydrated layer, and SS-NMR spectra do not confirm this analogy [7]. In
addition, carbonate ions can be incorporated in this layer, although they are not incorporated in OCP.
3. Preparation and formation conditions of biomimetic nanocrystalline apatites
Several methods have been proposed for the formation of nanocrystalline apatite [9,16,24,25,27];
however, the “biomimetic” criteria are not always met. One of the most developedmethods is probably
precipitation from supersaturated solutions like simulated body fluid (SBF) [16]. However, this method
does not allow the synthesis of large amounts of nanocrystals, and it does not facilitate control of their
maturation rate and composition. One of the most convenient syntheses is double decomposition
between a calcium salt solution and a phosphate (with or without carbonate) salt solution, with an
excess of phosphate (and carbonate) for solution buffering [27] (Table 1). Usually, the cationic solution
is rapidly poured into the anionic solution to confer the same ageing time to the nanocrystals. The
choice of precipitation conditions allows the preparation of crystals with different characteristics
corresponding, for example, to young or old bone mineral crystals [20]. Although drying changes the
surface structure layer, freeze-drying preserves some surface characteristics and most of the reactivity.
The nanocrystals' characteristics may vary depending on synthesis and post-synthesis parameters [27].
Analyses of the nanocrystals produced shall be done using different techniques in order to assess their
main physico-chemical characteristics such as chemical composition, crystal shape and morphology,
presence and extent of the hydrated layer. A stabilization of the hydrated layer has been observed with
mineral ions like Mg2þ and CO3
2".
4. Properties of biomimetic nanocrystalline apatites
The surface reactivity of BNA is related to their hydrated layer. The mineral ions in this layer appear
relatively mobile and may participate to different reaction such as ageing in solution, ion exchange,
molecular adsorption and dissolution properties. This layer also determines the interactions between
crystals, crystals and surfaces, and crystals and macromolecules.
4.1. Ageing in solution (maturation)
Biomimetic apatite nanocrystals are unstable and upon ageing in solution the proportion of ions in
the surface hydrated layer decreases and that of ions in the apatite domain increases (maturation). The
driving force behind this process is the development of stable apatite domains. This phenomenon can
be slowed down when inhibitors of apatite crystal growth like Mg2þ or CO3
2" are present in the hy-
drated layer; however, it cannot be stopped.
When biomimetic apatite nanocrystals are put in an aqueous solution, several phenomena are
observed: an equilibration of the crystals corresponding to the dissolution of calcium and phos-
phate ions followed by a maturation process producing chemical changes and a loss of surface
reactivity. The maturation process can vary depending on the solution, the nanocrystals' charac-
teristics and the solid/solution ratio. For nanocrystalline apatites with low carbonate content, the
phosphate concentration in solution increases and the pH and solution Ca/P ratio decreases, leading
to an apparent incongruent dissolution [12]. These events can be related to the composition dif-
ference between the hydrated layer and the apatite domains: apatite is built mainly of PO4
3" ions
whereas the hydrated layer contains mainly HPO4
2" ions. In the course of maturation, the devel-
opment of stable apatite domains consumes ions from the hydrated layer and induces deproto-
nation of HPO4
2" ions; the protons released in the hydrated layer react mainly with HPO4
2" to give
H2PO4
" ions, which are not retained and are eventually rejected into the solution leading to its
acidification (Fig. 2).
Over the long term, the increased acidity of the solutionmay lead to an increase in the proportion of
the solid dissolved and the Ca/P ratio in solution may then increase, stabilizing the pH variation. When
the solid/solution ratio is very high, the acidification can be so strong that brushite or monetite crystals
can form.
Initially, even in a carbonate containing solution, the BNA contains very small amounts of carbonate,
essentially in non-apatitic environments, in the hydrated layer. These carbonate ions are incorporated
in the apatite domains during their growth. In this case, the release of H2PO4
" ions related to the
maturation process can be associated with that of bicarbonate ions, which can partly decompose:
HCO"3 / CO2 þ OH
" (1.4)
attenuating the pH decrease and the evolution of the solution Ca/P ratio. These phenomena have to be
considered when the biological activity of biomimetic nanocrystals is evaluated in vitro as well as
in vivo.
4.2. Ion exchange
The ions in the hydrated layer can be rapidly and reversibly exchanged by ions in the solution. Several
ion exchanges have been described, such as carbonate/hydrogen-phosphate, Mg/Ca or Sr/Ca. The ex-
change ratio depends on the ions involved and on the maturation stage, which determines the quantity
of ions in the hydrated layer. It has been shown that the quantity exchanged decreased when the
maturation time of the apatites increased [5,6]. Exchange experiments using 13C-carbonate ions have
revealed that only surface species were exchanged and that the apatite domains were not altered during
the exchange experiments [21]. Although the ion uptake from the solution in exchange experiments can
be well described as a Langmuir-type isotherm, this representation does not take into account the ion





using a Langmuir-type representation, (with Q the amount adsorbed, N the amount adsorbed at
saturation, K the Langmuir affinity constant and (Sr) the Sr ion activity in solution at equilibrium).
Considering an exchange of Ca ions from the nanocrystals (nc) with Sr ions from the solution (sol)
corresponding to the chemical reaction:
Sr2þ
ðsolÞ









with Kex the equilibrium constant of the ion exchange reaction (1.5), and (Ca) the calcium ion activity at
equilibrium in solution.
The second expression is similar to that of a Langmuir adsorption equilibriumwhere (Sr) is replaced
by the ratio (Sr)/(Ca). It allows us, however, to explain important characteristics of the exchange re-
action such as its stability upon diluting the solution or washing the samples: although these treat-
ments alter the Sr concentration in solution and should alter the amount of Sr taken up according to a
Langmuir type representation, they preserve, in fact, the (Sr)/(Ca) ratio, which is all that matters. To
remove the Sr ions from the surface, one must reduce this ratio, by adding calcium to the solution, for
example, or other ions able to displace Sr.
The composition of nanocrystalline apatites can be easily modified using ion exchange and matu-
ration, and heterogeneous compositions can be obtained within the nanocrystals. Several types of ions
in the hydrated layer shall be distinguished:
! Ions that can be incorporated in the growing apatite domains like Sr2þ, CO3
2" (and probably many
others), which become non-exchangeable once they have entered the apatite domains (unless these
apatite domains are destroyed)
! Ions that cannot enter the apatite domains, or that penetrate in very limited quantities into calcium
phosphate apatites, like Mg2þ, which remain on the surface and can be exchanged at any time.
4.3. Adsorption of molecules
Adsorption is an important property of nanocrystalline apatites. Several types of interactions can be
involved in the adsorption of molecules, as shown, for example, in theoretical modelling. However the
strongest interactions seem to involve surface ion exchanges, which are not generally considered in
models. Several publications have shown, for example, that the adsorption of molecules with negative
functional groups is generally related to a phosphate (or carbonate) release [10,14,18]. Inversely, the
separation of biological molecules by chromatography on apatite substrates involves the use of a
phosphate solution with a concentration gradient [1]. Considering that the most important adsorption
reactions are, in fact, related to a surface ion exchange, the maturation stage, composition and
development of the hydrated layer play a significant role in the adsorption process, although only a few
data have been reported on this subject [20].
The molecules' adsorption is generally well represented by a Langmuir-type isotherm or some
derivatives. However, if it is assumed that the adsorption is in fact a surface ion exchange, these
representations, as explained in the previous paragraph, do not consider the implications of the ions
displaced in the chemical equilibrium and more accurate equations can be used which can explain the
apparent irreversibility of the adsorption phenomena upon dilution or washing [10]. It is generally
observed that the amount adsorbed at saturation is higher for immature nanocrystals with a well-
developed hydrated layer and decreases with the maturation time. The Langmuir affinity constant
(or the exchange equilibrium constant) also varies according to the characteristics of the biomimetic
nanocrystalline apatite substrate. The number of phosphate ions displaced per adsorbedmolecules has
been determined in a few cases and it depends on the molecules that are adsorbed [18] and on the
characteristics of the nanocrystals. The number of displaced ions is not necessarily an integer and it has
been suggested that adsorption could involve several steps [20].
4.4. Solubility behaviour
Several reports have revealed some variability in the dissolution properties of biological nano-
crystalline apatites: preferential dissolution of carbonated domains, non-congruency (different min-
eral ion ratios in the solution and in the solid) or variable solubility products. This last phenomenon has
been systematically studied [13] and it has been shown, in case of biological as well as synthetic
samples, that the solubility products of nanocrystalline apatites could vary according to the amount
dissolved, leading to the concept of metastable equilibrium solubility (MES). Although several expla-
nations can be given for this observation, this behaviour could be related to existence of a hydrated
layer. Currently, however, no indication of the evolution of the hydrated layer with the dissolution rate
of the nanocrystals has been established.
5. Biomimetic nanocrystalline apatites in biomaterials
Biomimetic nanocrystalline apatites appear as very reactive and metastable compounds and they
begin to decompose at about 200 'C, which does not favour their transformation into materials and
their use as biomaterials. Among the different technical issues that must be solved are processing and
shaping techniques, and the preservation of the physicalechemical and biological properties of bio-
mimetic nanocrystalline apatites.
5.1. Processing of biomimetic nanocrystalline apatites for use as biomaterials
Several strategies have been used to produce bioactive orthopedic biomaterials using biomimetic
nanocrystalline apatites, among which one can distinguish in situ formation, which allows the for-
mation of nascent BNA with a high reactivity, and low temperature shaping.
5.1.1. In situ formation
The formation of a layer of nanocrystalline apatite from body fluids in vivo is being considered as a
criterion for biological activity [16]. The ability of amaterial surface to nucleate andgrowananocrystalline
apatite layer in vitro from simulated body fluids (SBF) has even become a standard (ISO standard 14630).
Several techniques can be used to promote the formation of this layer, although very often only the
structure and nanometric dimensions of the crystals are considered and the chemical composition and
developmentof thehydrated layerarevery rarelymentioned.Twotypesof in situ formationofneo-formed
nanocrystalline apatite and, correlatively, of biomaterial classes may be recognized:
! “Passive” biomaterials that favour the nucleation of nanocrystalline apatites without participating
in the building up of the layer (in this group are apatites but also other nucleators of apatite, like
titanium oxide and collagen).
! “Active” biomaterials that interact chemically with body fluids and increase their supersaturation
locally with regard to apatite (biological glasses releasing Ca2þ ions, calcium carbonate, different
calcium or phosphate salts).
In addition to these materials, another important class of biomaterials able to produce nano-
crystalline apatites in situ is calcium phosphate cements. BNA are produced during the setting reactions
of a number of cements and their characteristics vary, often considerably, depending on the compo-
sition of the cements and the setting conditions.
5.1.2. Low temperature shaping
Among other techniques that have been proposed to make materials from biomimetic apatite
nanocrystals are gel setting, low temperature sintering, low temperature coatings and composite as-
sociations with polymers [22].
In all of these techniques the properties of the hydrated layer with its mobile mineral ions can be
used to promote interactions:
! Intercrystalline interactions, for example, to build cohesive materials, as in spark plasma sintering
(150 'C) of biomimetic nanocrystalline apatites at very low temperature [11].
! Interactions with a substrate to obtain an adhesive coating [2].
! Interactions with a polymer to obtain composite materials.
5.2. Biological properties and preservation of the BNA
The maturation of BNA can produce strong alterations in the aqueous media in contact with ma-
terials. In cell culture evaluations involving a very limited amount of solution in contact with materials
exposing a large surface area, these phenomena can be unacceptable as they strongly change the so-
lution pH and composition [12]. To avoid these alterations one can use low solid/solution ratios and
pre-equilibrate the material with the cell culture media. The changes induced by BNA are, however,
strongly dependent on their maturation stage and freshly prepared samples are the most reactive.
Another complication for interpreting results is the progressive change in the material itself due to the
maturation process [19].
The same maturation processes should occur in vivo but they have not really been studied. One
can reasonably estimate that the buffering effect in vivo is much stronger than in cell culture wells
and no adverse reactions have been reported concerning materials containing or inducing BNA
formation. Implantation results in non-osseous sites have even shown an osteoinductive behaviour
for BNA coatings on biphasic calcium phosphate ceramics [2]. However, the reason for this behaviour
has not been clarified. Considering the correspondence between the solubility of a calcium phos-
phate and its bioabsorption capability, it can be inferred that mature BNA should resorb slower than
non-mature BNA for similar types of materials, but there is presently no experimental support for
this proposition.
The reactivity of BNA seemsessentially related to thehydrated surface layer. Freeze-drying is probably
the best way to preserve this layer, although there is an amorphization of the surface layer and particle
aggregations occur. If freeze-dried samples are rehydrated the original structure seems partly reestab-
lished, but there is a loss of reactivity and, for example, a reduced ion exchange capacity. As already
mentioned, partial stabilization of the hydrated layer can occur when it incorporates apatite crystal
growth inhibitors like carbonate ormagnesium ions. Other crystal growth inhibitors (like pyrophosphate
ions, protein adsorption) might well play an equivalent role but experimental evidence is scarce.
6. Conclusion
Although biomimetic nanocrystalline apatites have not yet received the industrial development of
other traditional calcium phosphate ceramics, their reactivity and adaptable physicalechemical
characteristics offer decisive advantages for biological applications. However the nanosize character of
these compounds should not be considered as their sole advantage. Behind the nano label there are a
variety of chemical composition and reactivity issues that need to be explored and distinguished. The
recent improvement in the characterization techniques for BNA and in understanding and controlling
their reactivity in aqueous media should considerably favour the study and control of their biological
effects and their biomedical applications.
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